Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of business
Generic drugs are the singularity of American healthcare – they are too cheap. And it’s driving some manufacturers out of business altogether.
Drug prices regularly sparks recrimination and outrage on Capitol Hill, such as a recently announced investigation by Senate Democrats and Bernie Sanders into the price of albuterol inhalers.
More Stories
Researchers create AI-based tool that restores age-damaged artworks in hours
‘We’re being attacked all the time’: how UK banks stop hackers
Australia has ‘no alternative’ but to embrace AI and seek to be a world leader in the field, industry and science minister says